Early Mobilization and No Urinary Catheter After Cesarean for Improved Post Operative Recovery: A Randomized Trial
Impact of Promoting Early Mobilization and Eliminating Urinary Catheterization on Post-Cesarean Recovery: A Randomized Control Trial
1 other identifier
interventional
260
1 country
1
Brief Summary
ERAS (Enhanced Recovery After Surgery) is a set of steps used around surgery to help patients recover faster and better. ERAS guidelines have been adopted in several surgical fields, and evidence-based recommendations have recently been developed for cesarean delivery as well. These guidelines address multiple parts of post-operative care, including prevention of nausea and vomiting, pain control, thromboprophylaxis, early mobilization, urinary catheter use, and discharge counseling. Early mobilization is a key element of ERAS, but there is currently limited high-quality evidence about its specific benefits after cesarean delivery. In theory, mobilizing earlier may reduce thromboembolic events, shorten hospitalization, and speed up return of bowel function. Another important ERAS component is avoiding routine urinary catheter use. Evidence suggests that a no-catheter policy can shorten the time to first mobilization, first eating, and first bowel movement, and can reduce overall hospital stay compared with routine catheter use around cesarean delivery. In a randomized controlled trial of 300 women assigned to immediate versus delayed (12-hour) catheter removal after cesarean delivery, immediate removal reduced bacteriuria and urinary symptoms (dysuria, frequency, urgency), and also shortened time to first mobilization and length of stay. A systematic review also found that inserting a catheter before cesarean delivery increases the risk of urinary tract infection without improving surgical ease. A 2014 Cochrane review concluded that routine catheter use increases time to first urination, increases discomfort, delays mobilization, and prolongs hospital stay. The aim of the present study is to compare early mobilization combined with no urinary catheter in women undergoing planned cesarean delivery versus standard perioperative care, to improve recovery after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2025
CompletedFirst Submitted
Initial submission to the registry
April 26, 2026
CompletedFirst Posted
Study publicly available on registry
October 1, 2026
CompletedOctober 1, 2026
October 1, 2021
3.2 years
April 26, 2026
September 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Enhanced recovery
composite outcome scoring positive on 2/3 components: Recovery questionnaire score above 118, step count above 454 and non opioid use
24 hours
Secondary Outcomes (11)
Inability to Ambulate on First Postoperative Attempt
At first postoperative ambulation attempt- between 4-8 hours postoperative
Pre and post ambulation Pain Score on the Visual Analog Scale
Immediately before and after first postoperative ambulation
Postoperative Pain Score at 2-12 Hours
2-12 hours after surgery
Maternal Satisfaction Score at 24 Hours and 1 week after surgery and in comparison to previous Cesarean Section
24 hours and 1 week after surgery
Post-surgical Complication Within 7 Days of surgery
From surgery through postoperative day 7
- +6 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONUrine catheter at surgery and regular ambulation after 8 hours
enhanced ERAS
EXPERIMENTALOmission of urinary catheter and early ambulation after 4 hours
Interventions
Eligibility Criteria
You may qualify if:
- elective surgery
- Singleton
You may not qualify if:
- placenta accreta
- Limited mobility
- Allergy to nsaids/paracetamol/optalgin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bnei Zion
Haifa, Israel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2026
First Posted
October 1, 2026
Study Start
October 21, 2021
Primary Completion
January 6, 2025
Study Completion
September 10, 2025
Last Updated
October 1, 2026
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- May 2026
- Access Criteria
- ualified researchers may request access to de-identified individual participant data and supporting information by contacting the study team at liannapinsky@gmail.com. Requests will be reviewed by the investigators, and access will be granted for scientifically valid research purposes after approval of the request and completion of a data access/use agreement.
De-identified individual participant data (including data dictionary) will be shared. Requests may be submitted to liannapinsky@gmail.co. Access will be provided to qualified researchers for analyses under a data use agreement.